GlassScriptPhysician profile
Diana Li
NPI 1164900700
$2,340.68
in general payments reported to CMS, 2019-2025
11 companies · $487 in 2025
The $487 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2021: $26.77 · 2022: $179 · 2023: $310 · 2024: $482 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,066.92 | 2019-2025 | Dailies Total1, Total30, Precision7 |
| Coopervision INC. | $397.41 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Canon Medical Systems USA, INC. | $197.81 | 2019 | |
| Shire North American Group INC | $140.84 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $131.79 | 2024 | Xdemvy |
| Allergan, INC. | $124.08 | 2022 | |
| Abb Con-Cise Optical Group LLC | $115.89 | 2019 | |
| Biotissue Holdings INC. | $84.55 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $36.74 | 2022 | |
| Plexus Optix, INC. | $26.77 | 2021 | |
| Abbvie INC. | $17.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.